Since 2003, Adnan has been a Consultant Ophthalmologist at Moorfields Eye Hospital NHS Foundation Trust and was awarded the title of Professor at The Institute of Ophthalmology, UCL (University College London) in recognition of his contribution to eye research. He is the clinical and research lead at Moorfields Eye Hospital in London for age-related macular degeneration (AMD). Adnan was the lead clinician scientist for clinical trials to treat choroidal neovascularisation, including the seminal ABC Trial that focused on examining bevacizumab for neovascular AMD and the REPAIR trial for myopia related neovascularisation.
His current research interests are wide ranging from disease mechanisms and treatment discovery e.g. dry age-related macular degeneration, currently an untreatable condition, to using artificial intelligence systems to improve patient access to retinal care and creating safe data sharing so that physicians can pool their patient experience to improve eye care in the NHS. He is a pioneer of big data and machine learning in ophthalmology, with numerous publications to his name on that topic to date. He founded an ARVO AI special interest group that grew into an all-day course, and is involved in the validation of machine learning algorithms that are being introduced into the UK for diabetic screening. He is also Deputy Lead of the large 16 million euro multicentre European study of dry age-related macular degeneration MACUSTAR. Surgically he specialises in cataract surgery in patients with retinal disorders.
In addition to his NHS and University posts, Professor Tufail practices at Moorfields Eye Hospital Private Clinic, The London Claremont Clinic and the London Medical Clinic, Marylebone.
